Calgary company offers increased COVID-19 testing capability with versatile CoviLamp
CardiAl CEO Dr. Anmol Kapoor says this would allow AHS to ramp up its current capacity from the average 12,000 to 13,000 daily tests to about 100,000 tests a day
Rapid COVID-19 test -Disrupting medicine for the global good
On this episode of On the Levvel, we learn that Dr. Kapoor’s passion for equality, medicine, and education has made him a disruptor by wanting to streamline the antiquated lab process. His CoviLamp test is an advanced isothermal amplification of the COVID virus.
Calgary company offers increased COVID-19 testing capability with versatile CoviLamp
CardiAl CEO Dr. Anmol Kapoor says this would allow AHS to ramp up its current capacity from the average 12,000 to 13,000 daily tests to about 100,000 tests a day
Rapid COVID-19 test -Disrupting medicine for the global good
On this episode of On the Levvel, we learn that Dr. Kapoor’s passion for equality, medicine, and education has made him a disruptor by wanting to streamline the antiquated lab process. His CoviLamp test is an advanced isothermal amplification of the COVID virus.
Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.
Calgary Biotech Company "CardiAI" Receives Provincial Regulatory Approval for New Laboratory
CALGARY, Alberta — Calgary-based Canadian healthcare innovator and biotech company, CardiAI Inc. announced today that its new state-of-the-art laboratory has met all the Provincial regulatory requirements to run various diagnostic tests including the COVID-19 CoviLamp-PCR and COVID-19 antibody tests.
Biotech Company CardiAI Opens Chest Pain Clinic in South Calgary
Calgary, Alta (June 7, 2021) - Calgary-based biotech company CardiAI is launching a new clinical trial studying the long-lasting effects of COVID-19 on the pulmonary system at its new Chest Pain Clinic (250, 8500 Blackfoot Trail SE). The ACT study (Anti-Coronavirus Therapies) will evaluate if anti-inflammatory therapies prevent the progression of COVID-19 in both inpatients and outpatients.
MP Benzen's Spring 2021 Householder Albertans’ rapid test a Covid game-changer
Vaccines and rapid testing. The reopening of our economy and an end to the societal lockdowns that have devastated entire sectors depend on easy, nation-wide access to both.
A Calgary-based biotechnology company, CardiAI, holds one of the two keys, having developed the world’s most advanced PCR diagnostic test
Calgary-based biotechnology company launches on-site laboratory to provide rapid PCR COVID-19 testing with results within four hours
Calgary, Alberta (May 11, 2021) - Calgary-based Canadian healthcare innovator and biotech company, BioAro Inc., has launched an on-site COVID-19 rapid-test laboratory service at the Gahcho Kué diamond mine in the Northwest Territories (NWT), a joint venture between De Beers Group (the operator) and Mountain Province Diamonds.BioAro Inc. is a medical diagnostics
CardiAI and Carleton University Forge Innovative Partnership to Revolutionize Medical Diagnostics
CALGARY, AB, Feb. 27, 2024 /PRNewswire/ - Today, CardiAI, a leading Biotechnology company specializing in cutting-edge diagnostic solutions, proudly announced a groundbreaking partnership with Carleton University's Faculty of Engineering and Design, marking a significant milestone in advancing medical diagnostics through the implementation of Electrolyte Gated-FET (EG-FET) biosensor technology.